Medium severity · published Jan 8, 2021
CVE-2020-27260
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers…
5.3
CVSS
0.4%
EPSS
No
On KEV
Description
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages via multiple expected parameters.
CVSS vector
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
Attack vector
Physical
Complexity
Low
Privileges
None
User interaction
None
Confidentiality
None
Integrity
High
Availability
None
Scope
Changed
Exploitation
Is it being used?
Exploit prediction (EPSS)0.4% · higher than 38% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
VS
Vital Signs Monitor Vc150 Firmware · Innokasmedical
before 1.7.15 · source: NVD
Affected product
VS
Vital Signs Monitor Vc150 Firmware
Innokasmedical
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2020-27260
CVE.org
https://www.cve.org/CVERecord?id=CVE-2020-27260
Third Party Advisory
https://us-cert.cisa.gov/ics/advisories/icsma-21-007-01
More from Vital Signs Monitor Vc150 Firmware
5.4
CVE-2020-27262
Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 A stored cross-site scripting (XSS) vulnerability exists in the affected products that allow an attacker to…